scPharmaceuticals Inc

SCPH

Get informed when a big investor buys or sells

Market Cap$302.2M

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
scPharmaceuticals Inc	-5.4	-	430%	-	-2.5

$9.83

Current Fair Value

73.3% upside

Undervalued by 73.3% based on the discounted cash flow analysis.

Share Statistics

Market cap	$302.20 Million
Enterprise Value	$314.82 Million
Dividend Yield	$- (-)
Earnings per Share	$-1.91
Beta	0.3
Outstanding Shares	53,719,662

Return

Return on Equity	430.27%
Return on Assets	-114.28%
Return on Invested Capital	-112.90%

Valuation & Multiples

P/E Ratio	-5.38
PEG	-98.45
Price to Sales	-
Price to Book Ratio	-5.67
Enterprise Value to Revenue	6.3
Enterprise Value to EBIT	-4.66
Enterprise Value to Net Income	-4
Total Debt to Enterprise	0.17
Debt to Equity	-2.51

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

November 12, 2025

EPS Estimate

$-0.25

Average shareholder expectation

Revenue Estimate

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	0.2069▲ 20.69%
Total Calls	835,200▲ 10.36%
Total Puts	172,800▲ Infinity%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	76.24%▲ 5.14%
Total Invested	$232.21M▲ 59.55%
Investors Holding	117▲ 16.00%

ESG Score